Fidelis Pharmaceuticals develops and markets pharmaceutical formulations that meet specialized veterinary needs.
Fidelis Pharmaceuticals has raised $1.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.
Fidelis Pharmaceuticals's investors include Savitr Capital, Princeton Biopharma Capital Partners.
Fidelis Pharmaceuticals is headquartered in North Brunswick, United States.
Fidelis Pharmaceuticals develops and markets pharmaceutical formulations that meet specialized veterinary needs.
Fidelis Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fidelis Pharmaceuticals — Funding & Investors." VCBacked, February 28, 2024, https://www.vcbacked.co/company/fidelis-pharmaceuticals. Accessed August 13, 2026.
VCBacked. (2024). Fidelis Pharmaceuticals — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/fidelis-pharmaceuticals
{{cite web |title=Fidelis Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/fidelis-pharmaceuticals |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated